Related references
Note: Only part of the references are listed.18F-FDG PET/CT features of immune-related adverse events and pitfalls following immunotherapy
Martin H. Cherk et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2022)
18F-FDG PET/CT Imaging of Immune Checkpoint Inhibitor-Related Retroperitoneal Panniculitis
Fabio Minutoli et al.
CLINICAL NUCLEAR MEDICINE (2022)
Nivolumab Immunotherapy-Related Skin Reactions Detected on 18F-FDG PET/CT in Renal Cell Cancer
T. Thayumanavan et al.
CLINICAL NUCLEAR MEDICINE (2022)
Pembrolizumab-Induced Thyroiditis and Colitis-Presentation and Resolution on Serial FDG PET/CT
Ayah Adel Nawwar et al.
CLINICAL NUCLEAR MEDICINE (2021)
Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know
Luca Russo et al.
KOREAN JOURNAL OF RADIOLOGY (2021)
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
Steve Y. Cho et al.
SEMINARS IN NUCLEAR MEDICINE (2020)
18F-Fludeoxyglucose PET/Computed Tomography for Assessing Tumor Response to Immunotherapy and Detecting Immune-Related Side Effects A Checklist for the PET Reader
Kevin Prigent et al.
PET CLINICS (2020)
Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET/CT
Aurelie Moreau et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
Ahmed Mekki et al.
EUROPEAN JOURNAL OF CANCER (2018)
Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti-CTLA-4 Antibody Therapy
Yulia Bronstein et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)